Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism.
about
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancerVitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolismAnticoagulation for the long-term treatment of venous thromboembolism in patients with cancerAnticoagulation for the long term treatment of venous thromboembolism in patients with cancerAntithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesLow-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic reviewOnce daily enoxaparin for outpatient treatment of acute venous thromboembolism: a case-control study.Treatment of venous thromboembolism - effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant managementEvaluation and management of chronic pulmonary thromboembolic disease.Influence of sex on risk of bleeding in anticoagulated patients: a systematic review and meta-analysis.Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.Treatment of mobile right heart thrombi with low-molecular-weight heparinEarly discharge of patients with venous thromboembolism: implications regarding therapy.Sublingual administration of warfarin: a novel form of delivery.
P2860
Q24194904-AFCAD5D5-A242-4F97-BE87-600FE98ADFDBQ24198032-6B30FE7A-A1BE-423F-9037-51E650BBA90CQ24236620-48227C02-6F8F-40E2-BB48-6F1783BD1382Q24243286-F106F1FA-C664-4065-ABA7-57F3D1E931AEQ24633053-BCA7B499-5279-42F7-80F7-7070C271580CQ33380411-912E9E3C-F399-43A1-BF08-E6A4A4A5C329Q33382801-02D10391-F9FC-42AB-8CBC-7F0EDBAEC53CQ36561057-E29734B2-0CA5-4CBF-A9FF-6A113ED39D23Q37924503-D8FAD103-D6F3-422E-914D-361AF0F8D832Q38224507-FB314753-207F-4FDC-80F8-8080242FF225Q38664988-D80E362F-3ABC-4A15-9DE7-47D57955A9A6Q39652820-437A8CC4-78DD-480F-B485-6F5A68EC2B3BQ43260579-693CBBB6-FE15-4A50-B97B-F4C6A8E87B25Q46507540-92DCA21C-6D7D-4CFD-8D55-AE66B676EBEC
P2860
Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism.
@en
Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism.
@nl
type
label
Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism.
@en
Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism.
@nl
prefLabel
Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism.
@en
Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism.
@nl
P2093
P2860
P1433
P1476
Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism.
@en
P2093
Arthur A Sasahara
Nils Kucher
Rene Quiroz
Samuel Z Goldhaber
Sylvia McKean
P2860
P304
P356
10.1191/1358863X05VM634OA
P577
2005-11-01T00:00:00Z